Purpose. The aim of our study was to assess the regional cerebral blood flow (rCBF) of basal ganglia and thalami in patients with Parkinson's disease (PD) using perfusion-weighted magnetic resonance imaging (PW-MRI). Material and methods. Twenty subjects affected by idiopathic PD according to the United Kingdom Brain Bank criteria were enrolled in the study. Twenty normal subjects matched for age and gender were included as controls. After 20-day therapy withdrawal, the PD patients underwent PW-MRI. The rCBF was calculated both in patients and in controls. The regions of interest were manually positioned on rCBF maps over the caudate nucleus, the putamen, the external and internal globus pallidus, and over the ventrolateral nucleus of the thalamus. Data were normalised with those obtained from parieto-occipital white matter (POWM). Statistical analysis was performed using a parametric ANOVA test. Results. Patients showed a significant (p<0.01) interhemispheric asymmetry; rCBF values were higher on the more severely affected side. Controls showed no interhemispheric asymmetry. Conclusion. Our study suggests that PW-MRI is a valuable tool for assessing haemodynamic changes in PD patients. Haemodynamic change pattern may be useful in the early diagnosis of PD. 
Riassunto

Obiettivo. Lo scopo del nostro studio è stato quello di valutare il flusso ematico cerebrale (rCBF) a livello dei gangli della base e dei talami nei soggetti affetti da morbo di Parkinson (MdP) mediante risonanza magnetica perfusionale (pRM).
Materiali e metodi. Sono stati studiati 20 soggetti affetti da MdP idiopatico secondo i criteri della Brain
G. Simonetti Introduction
Parkinson's disease (PD) is a neurodegenerative disease marked by a degeneration of the dopaminergic neurons in the pars compacta of the substantia nigra (SN) [1] and of other brainstem pigments, as well as by the appearance of cell inclusions known as "Lewy's bodies" in the degenerating neurons. Diagnosis of PD is currently a clinical diagnosis only based on history, disease course, and finding of at least two of the three basic symptoms of the disease, i.e. rigidity, hypo-bradykinesia, and resting tremor, with typical asymmetry between the two sides of the body in terms of time of onset and symptom intensity. Furthermore, response to dopaminergic drugs over time is extremely important for diagnostic purposes. On the other hand, in the early stages of disease, it is impossible to arrive at a firm differential diagnosis between idiopathic PD and atypical vascular or degenerative Parkinsonisms on the sole basis of clinical data and initial response to treatment. Indeed, early PD, when symptoms are extremely mild and blurred, may show only a subtle, if any, response to dopaminergic therapy, just as subjects with atypical Parkinsonism may exhibit a limited response to therapy, which can persist for 1-2 years. Diagnosis based only of such criteria was found to be incorrect in 25% of cases subjected to post-mortem histological examination at the United Kingdom Brain Bank in London [2] . Interest in such a differential diagnosis lies mainly in the different course of these diseases and in the significant difference in how they respond to treatment.
The neuroimaging techniques that have been used in the differential diagnosis mainly rely on nuclear medicine methods, such as single proton emission computed tomography (SPECT) and positron emission tomography (PET) [3] [4] [5] [6] [7] [8] . Although these methods are extremely sensitive in the early detection of depleted nigrostriatal nerve endings and useful in the follow-up [9] [10] [11] , their limited availability (in particular in the case of PET), high costs, limited supply of tracers, and poor spatial resolution make them unsuitable as a routine aid in the early diagnosis of PD.
For instance, PET is unable to distinguish, within the basal nuclei, the putamen from the globus pallidus and even less the lateral from the medial pallidus. Many PET studies of PD have, in fact, analysed changes in receptor density, dopaminergic fibres, or metabolic changes in the "lenticular nucleus". This anatomical entity corresponds in humans to the putamen and external and internal globus pallidus taken as a whole. Current theories on the pathogenesis of PD assign often diametrically opposed functions to these structures.
An examination comprising them without differentiation [12, 13] carries a risk of underestimating those alterations. The reduced metabolism of the external pallidus should correspond to increased activity of the internal pallidus without affecting total activity [14] .
The purpose of this study was to use perfusion-weighted magnetic resonance imaging (PW-MRI) as a diagnostic method to identify a specific perfusion pattern in the basal ganglia of PD subjects. [3] [4] [5] [6] [7] [8] . Pur essendo tali metodiche altamente sensibili nel rilevare precocemente una deplezione delle terminazioni nervose nigro-striatali e utili nel follow-up della malattia [9] [10] [11] [12, 13] , rischia sicuramente di produrre una sottostima delle alterazioni. Infatti,
Materials and methods
We studied 20 subjects with idiopathic PD (11 men, nine women; mean age 68±3.2 years) according to the Brain Bank criteria [15] . Disease duration was 5±2.4 years. Only patients presenting with at least two of the three PD cardinal symptoms and a proven response to dopaminergic therapy were included. Subjects who presented with other neurological diseases and who did not respond to acute therapy were excluded from the study. In order to avoid any interferences caused by the effect of dopaminergic drugs on the basal ganglia flow [16] , the subjects were studied after at least 20 days' withdrawal of dopaminergic treatment. Twenty normal subjects matched by age and gender were studied as a control group. Before the MRI examination, all patients provided informed consent. This study was approved by our Ethics Committee. The study was conducted using a 1.5 Tesla Philips Gyroscan ACS-NT MRI magnet (Philips Medical Systems, Best, The Netherlands) with a 30-mT gradient intensity and a sinusoidal profile, and a standard quadrature brain coil. A sagittal T2-TSE sequence (slice thickness 3 mm, number of averages 3) was used to identify the two commissures on which we performed an axial T1-SE sequence, a T2-weighted sequence using cerebral spinal fluid (CSF) suppression [axial fluid attenuated inversion recovery (FLAIR)] with a FOV 230 mm, TE 150 ms, TR 6,000 ms, TI 2,000 ms, slice thickness 5 mm, gap 1 mm, matrix 256x256, number of averages 1, acquisition time approximately 3 min.
The PW-MRI study was carried out using a gradient echo (GE), T2*-weighted sequence with TR 620 ms, TE 30 ms, al diminuito metabolismo del pallido esterno dovrebbe corrispondere un aumento di attività in quello interno con una somma dei due probabilmente invariata [14] .
Lo slice thickness 7, gap 0 mm, number of averages 1, flip angle 40°, matrix 128x128, acquisition time 1.17 min, providing a set of dynamic T2-weighted contrast susceptibility images acquired during the passage of contrast material. Finally, the axial T1 sequence was repeated after administration of gadolinium. Gadolinium diethylene triamine pentaacetate (G-DTPA) paramagnetic contrast material (Magnevist, Schering, Berlin, Germany) was injected as a bolus, 0.4 mmol/kg, while the subjects held their eyes closed, via an 18-gauge needle cannula inserted into an antecubital vein of the arm using an automatic injector with a 4 ml/s flow rate. Perfusion data were processed by dedicated software on an independent console to obtain perfusion maps to calculate cerebral blood flow (rCBF) according to the technique previously reported by Apruzzese et al. [17] . Then, ten-pixel regions of interest (ROIs) were manually placed on the rCBF maps in the following regions: head of the caudate nucleus (CN), putamen (PU), external and internal globus pallidus (eGP/iGP) separately, and ventrolateral nucleus of the thalamus (TH). Perfusion data were also measured in the parietooccipital white matter (POWM) for normalisation (Fig. 1) . Pixels with signal intensity exceeding by 2 standard deviations (SD) the average values of the brain were excluded, as they probably corresponded to blood vessels. Perfusion data were calculated as the average of every ROI positioned on the basal nuclei and POWM on every side and values obtained were transformed into logarithms and normalised as a percentage of the value obtained with the ipsilateral POWM.
In order to determine asymmetries ("contrast" effect), the normalised data of each nucleus were expressed as the ratio between the nucleus being studied and the corresponding contralateral nucleus according to the formula: (R nucleus -L nucleus) / (R nucleus + L nucleus)*100. In PD patients, the formula was expressed as: [(less affected side -more affected side) / (less affected side + more affected side)*100] based on their clinical asymmetry. We used the third section of the Unified Parkinson's Disease Rating Scale (UPDRS) as a score of PD motor disability, ranging from 0 (normal) to 180 (maximum disability) [18] . The asymmetry index was calculated by subtracting the score of the less affected side from that of the more affected side. Data were analysed using STATISTICA software for Windows. Normalised data were analysed using parametric ANOVA tests, which include the following primary factors: "group" ('between' factor: PD vs. control subjects); "lateralization" ('within' factor: right side or better side vs. left side or worse side); "nuclei" ('within' factor: caudate, thalamus, putamen, external globus pallidus, internal globus pallidus). Greenhouse-Geisser correction was used when necessary. If a factor with more than two levels was significant or if interactions between factors were significant, Tukey's test was used as a post hoc test. In order to compare "contrast" data in the two groups, the factors "group" and "nuclei" were used.
Results
All patients with PD showed a significant (F(1/37)=7.98; p<0.01) difference in the average rCBF on the better side (bs) [18] . L'indice di asimmetria è stato calcolato sot-vs. the worse side (ws) as compared with control subjects ("group" x "side" interaction) (Fig. 2) . In patients with PD, this is due to a higher average baseline rCBF on the ws (117.6) as compared with the bs (107.3) (Fig. 3) , a finding which proved statistically significant (post hoc p<0.001). This variation was not observed in control subjects (110.9 vs. 111.2). This was confirmed by the "contrast" analysis, which showed a significant difference (F(1/37)=9.44; p<0.01) in mean contrast in the two groups (-4.39 vs. -0.064; PD vs. controls). The difference is similar in all the nuclei studied, with no significant "group"x"nuclei" interaction being found.
Sixteen of the 20 PD patients showed an abnormal "contrast index" in the putamen while 13 showed the same anomaly in the thalamus. Only five control subjects showed abnormal values in the putamen and none in the thalamus. Seven patients with PD had abnormal contrast values in all nuclei under study whereas these were normal in all control subjects.
Discussion
The diagnosis of PD remains largely clinical and is based on the presence of the three characteristic pathognomonic symptoms. The use of neuroimaging techniques has increased greatly over the last 10 years and has contributed to advancing the knowledge about the pathophysiology of many neurological diseases. In PD, today, brain MRI and SPECT and PET functional studies are usually applied for clinical and scientific purposes. PET and SPECT are still, however, very costly methods, use of which is restricted to a small number of highly specialised centres; hence, they cannot be proposed as screening tests. MRI, on the other hand, is far more widespread, less costly, and available in a number of radiology facilities. Over the last few years, various researchers have used PW-MRI to measure CBF in several diseases of neuroradiological concern. The literature does not provide information on possible altered flow values detected in degenerative diseases such as PD with traendo lo score del lato meno affetto da quello del lato più affetto.
Per Per comparare i dati "contrasto", nei due gruppi sono stati usati i seguenti fattori: "gruppo", "nuclei". (Fig. 3) PW-MRI. Our study, unique in its kind, aimed at evaluating perfusion alterations in the basal nuclei of PD subjects. Our data show a marked rCBF asymmetry between the more affected and the less affected side in the basal nuclei of patients with PD. A possible explanation of this result might be the loss of dopamine in the affected side, which could result in a maximum increase in the baseline rCBF on this side, an asymmetry that was never observed in control subjects. A relative asymmetry of rCBF in the basal ganglia has also been reported in other studies using PET in patients with unilateral or bilateral PD. Wolfson conducted a cerebral perfusion study using PET on patients affected by mild-to-moderate forms of unilateral and bilateral PD, finding blood flow asymmetry in the basal ganglia on both sides and with respect to controls. In this study, patients with bilateral PD showed no flow variation between the two sides. Other PET studies, on the other hand, did not find any asymmetry between homologous basal ganglia regions but only when the rCBF in basal ganglia was compared with the flow in critical cortical areas [19] . Our study partially confirms these findings, as previously described, by using a far less expensive method, such as PW-MRI. We were also able to detect a perfusion asymmetry in most PD patients (65%-80%) by analysing homologous sub-regions of basal nuclei, thanks to the higher resolution of MRI relative to PET. We believe that future studies analysing the ratio between cortical areas and basal ganglia might be useful to better demonstrate the abnormalities found in our investigation.
Risultati
Nella totalità dei pazienti con MdP si è dimostrato una significativa (F(1/37)=7,98; p<0,01) differenza dell'rCBF medio nel lato migliore (bs) vs. il lato peggiore (ws), rispetto ai soggetti controllo (interazione "gruppo" x "lato") (Fig. 2). Questo è dovuto, nei pazienti con MdP, ad un più alto rCBF medio, in condizioni basali, nel ws (117,6) rispetto al bs (107,3)
Conclusions
PW-MRI appears to be a valid method in the diagnosis of PD since it can identify blood flow asymmetry in the basal nuclei in both hemispheres. The low cost of this method, its wide availability, and its higher resolution compared with other functional imaging modalities (PET, SPECT) make PW-MRI extremely useful and expedient as a support tool for the early diagnosis of PD. 
